Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Tycoon Group Holdings Limited ( (HK:3390) ) has shared an update.
Tycoon Group Holdings Limited has announced a change in its board of directors, with Mr. Cao Weiyong resigning from his position as a non-executive director to pursue other business commitments, effective January 10, 2025. He will be succeeded by Mr. Hu Yang, who brings extensive experience in pharmaceutical operational and strategic management, and currently holds a significant role in China Resources Pharmaceutical Holdings Company Limited. This leadership transition is expected to bolster the company’s strategic operations, potentially impacting its market positioning and stakeholder interests.
More about Tycoon Group Holdings Limited
Tycoon Group Holdings Limited, incorporated in the Cayman Islands, operates in the pharmaceutical industry. The company is involved in the manufacturing and sale of pharmaceutical products and has a market focus on strategic management and operational effectiveness.
YTD Price Performance: -2.59%
Average Trading Volume: 964,557
Technical Sentiment Consensus Rating: Buy
Current Market Cap: HK$2.71B
See more data about 3390 stock on TipRanks’ Stock Analysis page.
